Bruker Cellular Analysis, Inc. Quarterly Return On Equity in % from Q4 2019 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Bruker Cellular Analysis, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2019 to Q2 2023.
  • Bruker Cellular Analysis, Inc. Return On Equity for the quarter ending June 30, 2023 was -87.5 %, a 104% decline year-over-year.
  • Bruker Cellular Analysis, Inc. annual Return On Equity for 2022 was -58.7 %, a 84.7% decline from 2021.
  • Bruker Cellular Analysis, Inc. annual Return On Equity for 2021 was -31.8 %, a 21.9% decline from 2020.
  • Bruker Cellular Analysis, Inc. annual Return On Equity for 2020 was -26.1 %, a 25.9% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2023 -87.5 -44.6 -104% Apr 1, 2023 Jun 30, 2023
Q1 2023 -63.3 -26.9 -73.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -58.7 -26.9 -84.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -47.1 -19 -67.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -42.9 -20.5 -91.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -36.4 -12.2 -50.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -31.8 -5.72 -21.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -28.2 -0.56 -2.03% Jul 1, 2021 Sep 30, 2021
Q2 2021 -22.4 +14.4 +39.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -24.2 +2.64 +9.84% Jan 1, 2021 Mar 31, 2021
Q4 2020 -26.1 -5.36 -25.9% Oct 1, 2020 Dec 31, 2020
Q3 2020 -27.6 Jul 1, 2020 Sep 30, 2020
Q2 2020 -36.8 Apr 1, 2020 Jun 30, 2020
Q1 2020 -26.8 Jan 1, 2020 Mar 31, 2020
Q4 2019 -20.7 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.